Correlation Between Cannara Biotech and Sonoma Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Sonoma Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Sonoma Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and Sonoma Pharmaceuticals, you can compare the effects of market volatilities on Cannara Biotech and Sonoma Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Sonoma Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Sonoma Pharmaceuticals.
Diversification Opportunities for Cannara Biotech and Sonoma Pharmaceuticals
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cannara and Sonoma is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Sonoma Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonoma Pharmaceuticals and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Sonoma Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonoma Pharmaceuticals has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Sonoma Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cannara Biotech and Sonoma Pharmaceuticals
Assuming the 90 days horizon Cannara Biotech is expected to under-perform the Sonoma Pharmaceuticals. But the otc stock apears to be less risky and, when comparing its historical volatility, Cannara Biotech is 1.13 times less risky than Sonoma Pharmaceuticals. The otc stock trades about 0.0 of its potential returns per unit of risk. The Sonoma Pharmaceuticals is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 268.00 in Sonoma Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 11.00 from holding Sonoma Pharmaceuticals or generate 4.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cannara Biotech vs. Sonoma Pharmaceuticals
Performance |
| Timeline |
| Cannara Biotech |
| Sonoma Pharmaceuticals |
Cannara Biotech and Sonoma Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cannara Biotech and Sonoma Pharmaceuticals
The main advantage of trading using opposite Cannara Biotech and Sonoma Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Sonoma Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonoma Pharmaceuticals will offset losses from the drop in Sonoma Pharmaceuticals' long position.| Cannara Biotech vs. Benchmark Botanics | Cannara Biotech vs. Speakeasy Cannabis Club | Cannara Biotech vs. City View Green | Cannara Biotech vs. BC Craft Supply |
| Sonoma Pharmaceuticals vs. China Pharma Holdings | Sonoma Pharmaceuticals vs. Universe Pharmaceuticals | Sonoma Pharmaceuticals vs. Akanda Corp | Sonoma Pharmaceuticals vs. Petros Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |